TY - JOUR
T1 - Geriatric assessment for older people with cancer
T2 - policy recommendations
AU - Seghers, P A L
AU - Alibhai, Shabbir M H
AU - Battisti, Nicolò Matteo Luca
AU - Kanesvaran, Ravindran
AU - Extermann, Martine
AU - O'Donovan, Anita
AU - Pilleron, Sophie
AU - Mislang, Anna Rachelle
AU - Musolino, Najia
AU - Cheung, Kwok-Leung
AU - Staines, Anthony
AU - Girvalaki, Charis
AU - Soubeyran, Pierre
AU - Portielje, Johanneke E A
AU - Rostoft, Siri
AU - Hamaker, Marije E
AU - Trépel, Dominic
AU - O'Hanlon, Shane
N1 - © 2023. Wuhan University Global Health Institute.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Most cancers occur in older people and the burden in this age group is increasing. Over the past two decades the evidence on how best to treat this population has increased rapidly. However, implementation of new best practices has been slow and needs involvement of policymakers. This perspective paper explains why older people with cancer have different needs than the wider population. An overview is given of the recommended approach for older people with cancer and its benefits on clinical outcomes and cost-effectiveness. In older patients, the geriatric assessment (GA) is the gold standard to measure level of fitness and to determine treatment tolerability. The GA, with multiple domains of physical health, functional status, psychological health and socio-environmental factors, prevents initiation of inappropriate oncologic treatment and recommends geriatric interventions to optimize the patient's general health and thus resilience for receiving treatments. Multiple studies have proven its benefits such as reduced toxicity, better quality of life, better patient-centred communication and lower healthcare use. Although GA might require investment of time and resources, this is relatively small compared to the improved outcomes, possible cost-savings and compared to the large cost of oncologic treatments as a whole.
AB - Most cancers occur in older people and the burden in this age group is increasing. Over the past two decades the evidence on how best to treat this population has increased rapidly. However, implementation of new best practices has been slow and needs involvement of policymakers. This perspective paper explains why older people with cancer have different needs than the wider population. An overview is given of the recommended approach for older people with cancer and its benefits on clinical outcomes and cost-effectiveness. In older patients, the geriatric assessment (GA) is the gold standard to measure level of fitness and to determine treatment tolerability. The GA, with multiple domains of physical health, functional status, psychological health and socio-environmental factors, prevents initiation of inappropriate oncologic treatment and recommends geriatric interventions to optimize the patient's general health and thus resilience for receiving treatments. Multiple studies have proven its benefits such as reduced toxicity, better quality of life, better patient-centred communication and lower healthcare use. Although GA might require investment of time and resources, this is relatively small compared to the improved outcomes, possible cost-savings and compared to the large cost of oncologic treatments as a whole.
KW - Humans
KW - Aged
KW - Geriatric Assessment
KW - Quality of Life
KW - Neoplasms/therapy
KW - Medical Oncology
KW - Policy
UR - https://pubmed.ncbi.nlm.nih.gov/37653521
U2 - 10.1186/s41256-023-00323-0
DO - 10.1186/s41256-023-00323-0
M3 - Article
C2 - 37653521
SN - 2397-0642
VL - 8
SP - 37
JO - Global Health Research and Policy
JF - Global Health Research and Policy
IS - 1
ER -